Repro India Limited (BOM:532687)
351.70
+5.75 (1.66%)
At close: Jun 5, 2026
Repro India Revenue
In the fiscal year ending March 31, 2026, Repro India had annual revenue of 4.94B INR with 6.02% growth. Repro India had revenue of 1.39B in the quarter ending March 31, 2026, with 13.33% growth.
Revenue
4.94B
Revenue Growth
+6.02%
P/S Ratio
1.02
Revenue / Employee
13.39M
Employees
369
Market Cap
5.04B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 4.94B | 280.30M | 6.02% |
| Mar 31, 2025 | 4.66B | -135.10M | -2.82% |
| Mar 31, 2024 | 4.79B | 575.10M | 13.63% |
| Mar 31, 2023 | 4.22B | 1.35B | 46.80% |
| Mar 31, 2022 | 2.87B | 1.49B | 108.22% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Subam Papers | 5.79B |
| Nisus Finance Services Co | 5.49B |
| Omax Autos | 4.84B |
| Andhra Cements | 4.52B |
| CSL Finance | 2.57B |
| Lokesh Machines | 2.09B |
| United Drilling Tools | 1.81B |
| Jenburkt Pharmaceuticals | 1.69B |